Showing results (31-40 of 319) with videos related to
Sort By:
Pageof 32
Japanese Journal of Clinical Oncology|January 27, 2006
Intermediate dose 5-fluorouracil-induced encephalopathyYeon-A Kim, Hyun Cheol Chung, Hye Jin Choi, et al.Breast Cancer Research and Treatment|June 26, 2007
Different criteria for HER2 positivity by IHC can be applied in post-chemotherapy specimens in determining HER2 as a prognosticator in locally advanced breast cancerYong Wha Moon, Hei-Cheul Jeung, Sun Young Rha, et al.Oncology Reports|August 3, 2007
Putative chemosensitivity predictive genes in colorectal cancer cell lines for anticancer agentsJae-Joon Jung, Hei-Cheul Jeung, Jung Ok Lee, et al.Japanese Journal of Clinical Oncology|August 4, 2007
Bilateral breast cancer: differential diagnosis using histological and biological parametersSoo Jung Gong, Sun Young Rha, Hei Cheul Jeung, et al.International Journal of Molecular Medicine|May 10, 2007
Integrated in silico and biological validation of the blocking effect of Cot-1 DNA on Microarray-CGHSeung-Hui Kang, Chan Hee Park, Hei Cheul Jeung, et al.Cancer Letters|March 5, 2008
Variation of the 3' telomeric overhang lengths in human cellsMyung Eun Lee, Sun Young Rha, Hei-Cheul Jeung, et al.Investigational New Drugs|April 28, 2012
Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agentSang Joon Shin, Jee Won Hwang, Joong Bae Ahn, et al.Cancer Gene Therapy|May 29, 2004
Tumor-specific gene therapy for uterine cervical cancer using MN/CA9-directed replication-competent adenovirusHo Yeong Lim, Miwon Ahn, Hyun Cheol Chung, et al.Journal of Radiation Research|August 28, 2012
Mechanism of enhancement of radiation-induced cytotoxicity by sorafenib in colorectal cancerYong Bae Kim, Hei-Cheul Jeung, Inhye Jeong, et al.Cancer Letters|April 16, 2025
Efficacy of the first-line immune checkpoint inhibitor plus chemotherapy for gastroesophageal cancer: A meta-analysis of phase III trials including unreported PD-L1 subgroupsChoong-Kun Lee, Sejung Park, Yaeji Lee, et al.Pageof 32